Drug intelligence / Profile preview

OsteoActivator-C

Development stage
Preclinical
Lead developer
Osteo Pharma
Modality
Small Molecules, Device-based Delivery → Drug Delivery Systems
Administration
Implant
01

Overview

OsteoActivator-C (OP003) is a Class 3 medical device developed by Osteo-Pharma BV. It consists of orthopedic implants coated with the proprietary OsteoActivator™ technology, which utilizes EMA and FDA-approved low molecular weight pharmaceuticals encapsulated within a biodegradable carrier. The device is designed to provide sustained release of these compounds over a 6-8 week period to enhance osseointegration and bone-implant fixation. Its mechanism of action involves simultaneously promoting bone formation and inhibiting bone resorption in the area adjacent to the implant. OsteoActivator-C is administered via surgical implantation and is primarily intended for orthopedic indications to improve implant stability and prevent loosening. Preclinical studies have demonstrated increased bone formation in trabecular bone adjacent to coated screws.

Other names
OsteoActivator-C

Beyond the preview

Go deeper on OsteoActivator-C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OsteoActivator-C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call